StimOxyGen

United Kingdom
Coleraine, Northern Ireland, United Kingdom, BT52 1SA

Company profile

StimOxyGen company profile

StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2021-01-01, Year

Headquarters

Postal code
BT52 1SA
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$1.9M
Last funding
Series Unknown / $1.9M / 2025-03-11
Last equity funding
Series Unknown / $1.9M
Investors
4
Lead investors
2
Founders
1
Articles
1

Founders and investors

Founders

Sian Farrell

Lead investors

DSW VenturesInnovate UK

Investors

Clarendon Fund ManagersDSW VenturesInnovate UKQUBIS